Spin-Off Research downgraded Solventum to Hold from Buy with a $73 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
- Solventum initiated with a Neutral at BofA
- Solventum backs FY24 adjusted EPS view $6.10-$6.40, consensus $6.27
- Solventum reports Q1 adjusted EPS $2.08, consensus $1.74
- Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update